MAZE (Maze Therapeutics) OCF Margin %: -195.57% (As of Mar. 2026)


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $26.86
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics OCF Margin %?

Maze Therapeutics MAZE +0.71% 14 OCF Margin % is -195.57% as of Mar. 2026. GuruFocus rates MAZE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Maze Therapeutics ranks worse than 75.52% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Maze Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-39.11 Mil. Maze Therapeutics's Revenue for the three months ended in Mar. 2026 was $20.00 Mil. Therefore, Maze Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -195.57%.

As of today, Maze Therapeutics's current OCF Yield % is -8.18%.

The historical rank and industry rank for Maze Therapeutics's OCF Margin % or its related term are showing as below:

MAZE' s OCF Margin % Range Over the Past 10 Years
Min: 45.35   Med: 45.35   Max: 45.35
Current: -607.69

During the past 4 years, the highest OCF Margin % of Maze Therapeutics was 45.35%. The lowest was 45.35%. And the median was 45.35%.

MAZE's OCF Margin % is ranked worse than
75.52% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs MAZE: -607.69

Maze Therapeutics OCF Margin % Related Terms

Maze Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Maze Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maze Therapeutics OCF Margin % Chart

Maze Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 45.35 0.00

Maze Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -195.57

MAZE vs FTRE, ARDX, MBX: OCF Margin % Comparison

For the Biotechnology subindustry, Maze Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maze Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maze Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Maze Therapeutics's OCF Margin % falls into.


MAZE
14GF Score
Maze Therapeutics Inc MAZE
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Maze Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-111.94/0
= %

Maze Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-39.113/20
=-195.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -195.57% mean?
Maze Therapeutics (MAZE) has a OCF Margin % of -195.57% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Maze Therapeutics and its competitors. Over the past decade, Maze Therapeutics' OCF Margin % has ranged from 45.35 to 45.35. According to the industry distribution chart, Maze Therapeutics ranks #725 out of 960 companies in the Biotechnology industry, placing it in the top 75.5%.
Is Maze Therapeutics' OCF Margin % too high?
Maze Therapeutics' current OCF Margin % is -195.57%. Over the past 10 years, this metric has ranged from a low of 45.35 to a high of 45.35. Based on the distribution chart, Maze Therapeutics ranks #725 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Maze Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' OCF Margin % compare to FTRE and ARDX?
According to the Biotechnology industry distribution chart, Maze Therapeutics ranks #725 out of 960 companies for OCF Margin %. This places Maze Therapeutics in the lower half of its industry. Historically, Maze Therapeutics' own OCF Margin % has ranged from 45.35 to 45.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current OCF Margin % is -195.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current OCF Margin % of -195.57%. The current OCF Margin % is -195.57%. Maze Therapeutics' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current OCF Margin % is -195.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.86
Price